Skip to main content
Top
Published in: Netherlands Heart Journal 9/2018

Open Access 01-09-2018 | ICIN

Einthoven dissertation prizes 2017

Author: J. J. Piek

Published in: Netherlands Heart Journal | Issue 9/2018

Login to get access

Excerpt

The dissertation prize is named after Willem Einthoven, a pioneer in cardiovascular medicine who recorded the first human ECG in 1902, for which he was awarded the Nobel prize in 1924 [1]. The annual Einthoven dissertation prize is an initiative of the Netherlands Heart Institute (NHI) and the Netherlands Society of Cardiology (NVVC) to select the top three cardiovascular theses published in the year 2017. The jury received a total of 26 PhD dissertations for selection. The ranking of the theses was based upon a combination of parameters that included the curriculum vitae of the candidate, the scientific originality of the PhD thesis and its relevance for the cardiovascular field. Moreover, several objective bibliometric parameters were used that included the number of articles in citation index journals, both in PubMed and the Web of Science (WOS), the number of citations in WOS, the Hirsch index and finally the contribution of the candidate as a first author. Based upon this evaluation the jury elected the following nominees: S. Bekkering, N. van Ditzhuijzen, and M. Hazebroek. The members of the jury were P.A. Doevendans and D.J. Duncker (Netherlands Heart Institute), H. Bosker (NVVC), I. van Gelder (CVOI) and M.J. Schalij (President Concilium Cardiologicum). The three candidates presented their PhD theses at the NHI meeting in Utrecht on June 28–29th 2018. We congratulate the laureates for their excellent scientific work and their presentations during the meeting. …
Literature
1.
2.
go back to reference Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8.CrossRefPubMed Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, et al. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37:1850–8.CrossRefPubMed
3.
go back to reference Hazebroek M, Krapels I, Verdonschot J, van den Wijngaard A, Vanhoutte E, Hoos M, Snijders L, van Montfort L, Witjens M, Dennert R, Crijns H, Brunner-La Rocca H, Brunner H, Heymans S. Prevalence of pathogenic gene mutations and prognosis do not differ in isolated left ventricular dysfunction compared to dilated cardiomyopathy. Circ Heart Fail. 2018; https://doi.org/10.1161/CIRCHEARTFAILURE.117.004682.CrossRefPubMed Hazebroek M, Krapels I, Verdonschot J, van den Wijngaard A, Vanhoutte E, Hoos M, Snijders L, van Montfort L, Witjens M, Dennert R, Crijns H, Brunner-La Rocca H, Brunner H, Heymans S. Prevalence of pathogenic gene mutations and prognosis do not differ in isolated left ventricular dysfunction compared to dilated cardiomyopathy. Circ Heart Fail. 2018; https://​doi.​org/​10.​1161/​CIRCHEARTFAILURE​.​117.​004682.CrossRefPubMed
4.
go back to reference Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015;199:170–9.CrossRefPubMed Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015;199:170–9.CrossRefPubMed
5.
go back to reference Riemersma M, Hazebroek MR, Helderman-van den Enden A, Salomons GS, Ferdinandusse S, Brouwers M, et al. Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017;25:1195–201.CrossRefPubMed Riemersma M, Hazebroek MR, Helderman-van den Enden A, Salomons GS, Ferdinandusse S, Brouwers M, et al. Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017;25:1195–201.CrossRefPubMed
6.
go back to reference Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430–41.CrossRefPubMed Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430–41.CrossRefPubMed
7.
go back to reference Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62:2046–72.CrossRefPubMed Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, et al. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013;62:2046–72.CrossRefPubMed
8.
go back to reference Hazebroek MR, Moors S, Dennert R, van den Wijngaard A, Krapels I, Hoos M, et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification. J Am Coll Cardiol. 2015;66:1313–23.CrossRefPubMed Hazebroek MR, Moors S, Dennert R, van den Wijngaard A, Krapels I, Hoos M, et al. Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification. J Am Coll Cardiol. 2015;66:1313–23.CrossRefPubMed
10.
go back to reference Merken J, Hazebroek M, Van Paassen P, Verdonschot J, Van Empel V, Knackstedt C, et al. Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy. Circ Heart Fail. 2018;11:e4228.CrossRefPubMed Merken J, Hazebroek M, Van Paassen P, Verdonschot J, Van Empel V, Knackstedt C, et al. Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy. Circ Heart Fail. 2018;11:e4228.CrossRefPubMed
Metadata
Title
Einthoven dissertation prizes 2017
Author
J. J. Piek
Publication date
01-09-2018
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 9/2018
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-018-1136-y

Other articles of this Issue 9/2018

Netherlands Heart Journal 9/2018 Go to the issue